Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling

BACKGROUND: Pancreatic cancer (PC) is aggressive and with poor clinical prognosis. However, mechanisms underlying the aggressiveness of PC remain unclear. Increasing evidence indicates that cholesterol, a major source of bio-energy, is required for the progression of human cancers including PC. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Shang, Chen, Qingqing, Xu, Yingying, Zhuang, Qianfeng, Ji, Shengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798715/
https://www.ncbi.nlm.nih.gov/pubmed/35117491
http://dx.doi.org/10.21037/tcr.2020.01.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798715/
https://www.ncbi.nlm.nih.gov/pubmed/35117491
http://dx.doi.org/10.21037/tcr.2020.01.27

Ejemplares similares